Clinical Trials Directory

Trials / Unknown

UnknownNCT01402154

EPISPOT Detection of Circulating Prostate Cells Among Adenocarcinoma Patients

The Pre-treatment Detection of Circulating, Functional, Prostate Cells Among Adenocarcinoma Patients: an Evaluation of the EPISPOT Technique

Status
Unknown
Phase
Study type
Observational
Enrollment
361 (actual)
Sponsor
Centre Hospitalier Universitaire de Nīmes · Academic / Other
Sex
Male
Age
18 Years
Healthy volunteers
Not accepted

Summary

The primary objective of this study is to evaluate the predictive value (in terms of remission) of a new technique for detecting circulating, functional, prostate cells among patients with localized adenocarcinoma of the prostate, and prior to any treatment.

Conditions

Interventions

TypeNameDescription
BIOLOGICALEPISPOT detection of the number of circulating cellsEPISPOT detection of the number of circulating, functional, prostate cells per unit blood
BIOLOGICALCellSearch detection of the number of circulating, functional, prostate cellsCellSearch detection of the number of circulating, functional, prostate cells per unit blood

Timeline

Start date
2012-01-03
Primary completion
2014-12-08
Completion
2021-12-01
First posted
2011-07-26
Last updated
2021-08-05

Locations

5 sites across 1 country: France

Source: ClinicalTrials.gov record NCT01402154. Inclusion in this directory is not an endorsement.

EPISPOT Detection of Circulating Prostate Cells Among Adenocarcinoma Patients (NCT01402154) · Clinical Trials Directory